scholarly article | Q13442814 |
P356 | DOI | 10.1002/PST.1688 |
P8608 | Fatcat ID | release_dsftbm7zvfbxddxtjm6kn5myyq |
P698 | PubMed publication ID | 25958984 |
P50 | author | Maarten J. Postma | Q87840199 |
P2093 | author name string | Petros Pechlivanoglou | |
Ernst Wit | |||
Fentaw Abegaz | |||
P2860 | cites work | Indirect comparisons of competing interventions | Q28183606 |
Combination of direct and indirect evidence in mixed treatment comparisons | Q29619499 | ||
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials | Q29619501 | ||
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis | Q34604680 | ||
Bayesian methods for evidence synthesis in cost-effectiveness analysis | Q36381197 | ||
Evaluation of networks of randomized trials | Q36966424 | ||
Evidence synthesis for decision making 6: embedding evidence synthesis in probabilistic cost-effectiveness analysis | Q36991726 | ||
Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons | Q37167644 | ||
Use of indirect and mixed treatment comparisons for technology assessment | Q37259556 | ||
Are adverse effects incorporated in economic models? An initial review of current practice | Q37657795 | ||
Network meta-analysis of randomized clinical trials: reporting the proper summaries | Q37678529 | ||
Checking consistency in mixed treatment comparison meta-analysis | Q37705195 | ||
Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment | Q44194059 | ||
Modeling between-trial variance structure in mixed treatment comparisons | Q45817322 | ||
Guidance on the implementation and reporting of a drug safety Bayesian network meta-analysis | Q46450711 | ||
Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. | Q46894544 | ||
Methods for incorporating covariate adjustment, subgroup analysis and between-centre differences into cost-effectiveness evaluations | Q50130117 | ||
Indirect comparisons: the mesh and mess of clinical trials. | Q51929967 | ||
Borrowing strength from external trials in a meta-analysis. | Q52287071 | ||
Bayesian approaches to random-effects meta-analysis: a comparative study. | Q52320769 | ||
P433 | issue | 4 | |
P304 | page(s) | 322-331 | |
P577 | publication date | 2015-05-07 | |
P1433 | published in | Pharmaceutical Statistics | Q7180744 |
P1476 | title | An alternative parameterization of Bayesian logistic hierarchical models for mixed treatment comparisons | |
P478 | volume | 14 |